Featured
Why Syndax Pharmaceuticals Inc. (SNDX) stock is decreasing rapidly?
Syndax Pharmaceuticals, Inc. (SNDX), a clinical-stage healthcare company that focuses on an HDAC inhibitor for tumors and specializes in cancer
Menu
Syndax Pharmaceuticals, Inc. (SNDX), a clinical-stage healthcare company that focuses on an HDAC inhibitor for tumors and specializes in cancer
Canadian National Railway Co announced their offer to acquire railroad operator Kansas City Southern for $30 billion, potentially snatching the
Baosheng Media Group Holdings Limited (BAOS) stock prices were up to USD$5.62 after a marginal uptrend of 0.09% as of
SOS Limited (SOS), a Chinese tech service company providing blockchain services and specializing in marketing data, is facing an investigation
Sundial Growers Inc. (SNDL) stock price went up by 11.06% as of market close on April 19th, 2021, settling in
Catabasis Pharmaceuticals, Inc. (CATB) stock prices enjoyed an 8.48% uptrend as of market close on April 19th, 2021, settling into
Northern Dynasty Minerals Ltd. (NAK) stock prices were up 11.17% as of market close on April 19th, 2021, settling in
Ambow Education Holding Ltd (AMBO), China’s leading provider of premium education and global cultural exchange services, announced to initiate its
Cricut, Inc (CRCT) stock prices are up a very promising 14.30% as of market open on April 19th, 2021, hitting
Aqua Metals, Inc. (AQMS) stock prices are down more than 10% as of the market opening on April 19th, 2021,